Recall of Cannabis for Medical Purposes - Aurora Cannabis Enterprises Inc.

Starting date:

January 13, 2017

Type of communication:

Drug Recall

Subcategory:

Drugs

Hazard classification:

Type II

Source of recall:

Health Canada

Issue:

Undeclared Substance

Audience:

General Public

Identification number:

RA-61802

• 
  Reason
• 
  Affected products
• 
  Media enquiries

Introduction

On January 13, 2017, Aurora Cannabis Enterprises Inc., a licensed producer of cannabis for medical purposes located in Alberta, began a voluntary recall of seven lots of product under a Type II recall. The product that is being recalled includes dried marijuana that was produced by Organigram Inc. and sold by Aurora Cannabis Enterprises Inc. to their clients. The affected lot numbers are found below.

Reason

Between August to October 2016, Aurora Cannabis Enterprises Inc. purchased various lots of products from Organigram Inc. and sold these lots to their clients under the name Aurora Cannabis Enterprises Inc.

On January 9, 2017, Organigram Inc. initiated a voluntary Type II recall, following testing which identified lots containing residual levels of myclobutanil and/or bifenazate which are not found in the thirteen pesticides that are authorized for use on cannabis plants under the Pest Control Products Act. These two ingredients are found in pest control products that are approved for use in food production.

The lots purchased by Aurora Cannabis Enterprises Inc. are affected by the Organigram Inc. recall, as test results for some of these lots may contain residual levels of myclobutanil and/or bifenazate that exceed any of the levels permitted in food production for these two pesticides. As a precautionary measure, on January 13, 2017, Aurora Cannabis Enterprises Inc. initiated a voluntary Type II recall of product lots sold to their clients that was produced by Organigram Inc.

A Type II recall refers to a situation in which the use of, or exposure to a product may cause temporary adverse health consequences, or where the probability of serious adverse health consequences is remote.

To date, Health Canada has not received any adverse reaction reports for products sold by Aurora Cannabis Enterprises Inc.  However, Health Canada recommends that any individual affected by the recall immediately stop using the recalled product and to contact Aurora Cannabis Enterprises Inc. at the following number 1-604-331-3434.

Affected products

Media enquiries

Health Canada

(613) 957-2983